Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer.
Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer. Semin Dial. 2009 Jan-Feb; 22(1):1-4.